Purpose of this document
The purpose of this national policy document is to:-
- define the arrangements for the quality assessment of licensed medicines in support of the national contracting process.
- define the roles and responsibilities of Regional Quality Assurance (QA) specialists in the contracting process for licensed medicines
- ensure equity and consistency of the quality and medication error potential assessment process and ongoing contract support
- to define the process for reporting the outcome of the quality and medication error potential assessments to contracting teams and purchasers to support risk based decision making.